Provided by Tiger Trade Technology Pte. Ltd.

Connect Biopharma Holdings Ltd.

1.10
+0.108010.89%
Post-market: 1.100.00000.00%19:59 EDT
Volume:165.63M
Turnover:264.20M
Market Cap:69.26M
PE:-0.92
High:1.89
Open:1.89
Low:1.07
Close:0.9920
52wk High:3.82
52wk Low:0.9800
Shares:62.96M
Float Shares:21.58M
Volume Ratio:117.28
T/O Rate:767.44%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.1933
EPS(LYR):-1.0000
ROE:-140.51%
ROA:-69.75%
PB:2.58
PE(LYR):-1.10

Loading ...

Connect Biopharma - Rademikibart Well Tolerated with Low Incidence of Adverse Events in Asthma Patients

THOMSON REUTERS
·
Sep 15

Connect Biopharma - Rademikibart Reduces Treatment Failure Rate by 66% at 28 Days vs Placebo

THOMSON REUTERS
·
Sep 15

Connect Biopharma - Rademikibart Shows Statistically Significant Lung Function Improvement at Day 7 vs Placebo

THOMSON REUTERS
·
Sep 15

Connect Biopharma - Plans to Meet with FDA Regarding Phase 3 Program for Rademikibart

THOMSON REUTERS
·
Sep 15

CNTB: Buy Rating Reiterated with Unchanged $7 Price Target Ahead of Seabreeze Trial Catalysts

TIPRANKS
·
Sep 11

US Closing Bell | Tech rebound pushes Nasdaq up 1.4% as Snowflake and Tesla soar

US Closing Bell
·
Sep 04

Top Premarket Gainers

MT Newswires Live
·
Aug 31

Canaccord Genuity Sticks to Their Buy Rating for Connect Biopharma Holdings (CNTB)

TIPRANKS
·
Aug 26

Connect Biopharma Holdings Ltd Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 17

Connect Biopharma Holdings Ltd Expected to Post a Loss of 21 Cents a Share - Earnings Preview

Reuters
·
Aug 14

Analysts Offer Insights on Healthcare Companies: Connect Biopharma Holdings (CNTB) and Biomea Fusion (BMEA)

TIPRANKS
·
Aug 13

Connect Biopharma Hldgs Q2 EPS $(0.27) Beats $(0.31) Estimate, Sales $2.768M Beat $650.000K Estimate

Benzinga Earnings
·
Aug 13

Connect Biopharma - Expects Topline Results from Phase 2 Seabreeze Stat Studies in September 2026

THOMSON REUTERS
·
Aug 13

Press Release: Connect Biopharma Reports Second Quarter 2026 Financial Results and Provides Business Update

Dow Jones
·
Aug 13

Connect Biopharma Posts Investor Presentation Highlighting Rademikibart Program in Asthma, COPD Exacerbations

Reuters
·
Jul 14

Connect Biopharma Holdings Ltd : Oppenheimer Initiates Coverage with Outperform Rating; Target Price $8

THOMSON REUTERS
·
Jul 09

Connect Biopharma Initiated at Overweight by Piper Sandler

Dow Jones
·
Jun 26

Connect Biopharma Holdings Ltd : Piper Sandler Initiates Coverage with Overweight Rating; Target Price $7

THOMSON REUTERS
·
Jun 26

U.S. Research Roundup-american Tower, H.B. Fuller Company, TD Synnex

Reuters
·
Jun 26

Connect Biopharma Price Target Maintained with a $7.00/share by HC Wainwright & Co.

Dow Jones
·
Jun 25